Ototoxicity Withdrawn Phase Trials for Dexamethasone (DB01234)

Also known as: Auditory toxicity / Ototoxicity (disorder)

IndicationStatusPhase
DBCOND0008838 (Ototoxicity)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02382068Dexamethasone in Preventing Hearing Loss in Patients Receiving CisplatinSupportive Care